Stock Events

Stock Events

Edwards Lifesciences 

$88.40
296
+$0.11+0.12%Wednesday 20:00
+$0.00+0%Wednesday 23:00After hours

Statistics

Day High
89.32
Day Low
87.06
52W High
96.29
52W Low
74.66
Volume
2,717,009
Avg. Volume
3,641,335
Mkt Cap
50.95B
P/E Ratio
49.84
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 4Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.55
0.63
0.7
0.78
Expected EPS
0.736675
Actual EPS
N/A

Financials

17.5%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.13BRevenue
1.07BNet Income

Analyst Ratings

$105.45Average Price Target
The highest estimate is ⁦110.00⁩.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
91%
Hold
9%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EW. It's not an investment recommendation.
Apple
79
AAPL
Microsoft
72
MSFT
Alphabet
72
GOOGL
NVIDIA
70
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap110.49B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap105.65B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap138.47B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap49.08B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap12.14B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap986.16M
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

About

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Show More
CEO
Bernard J. Zovighian
Employees
16000
Country
United States
ISIN
US28176E1082
WKN
000936853

Listings

STU
DE
EWL.STU
MU
DE
EWL.MU
MX
MX
EW.MX
LSE
GB
0REN.LSE

0 Comments

Share your thoughts

FAQs

What is Edwards Lifesciences stock price today?▼
The current price of EW is $88.40 USD — it has increased by +0.12% in the past 24 hours. Watch Edwards Lifesciences stock price performance more closely on the chart.
What is Edwards Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Edwards Lifesciences stocks are traded under the ticker EW.
Is Edwards Lifesciences stock price growing?▼
EW stock has risen by +0.34% compared to the previous week, the month change is a -0.43% fall, over the last year Edwards Lifesciences has showed a +15.04% increase.
What is Edwards Lifesciences market cap?▼
Today Edwards Lifesciences has the market capitalization of 50.95B
When is the next Edwards Lifesciences earnings date?▼
Edwards Lifesciences is going to release the next earnings report on November 4, 2026.
What were Edwards Lifesciences earnings last quarter?▼
EW earnings for the last quarter are 0.78 USD per share, whereas the estimation was 0.74 USD resulting in a +4.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Edwards Lifesciences revenue for the last year?▼
Edwards Lifesciences revenue for the last year amounts to 6.13B USD.
What is Edwards Lifesciences net income for the last year?▼
EW net income for the last year is 1.07B USD.
How many employees does Edwards Lifesciences have?▼
As of October 22, 2026, the company has 16,000 employees.
In which sector is Edwards Lifesciences located?▼
Edwards Lifesciences operates in the Health & Wellness sector.
When did Edwards Lifesciences complete a stock split?▼
The last stock split for Edwards Lifesciences was on June 1, 2020 with a ratio of 3:1.
Where is Edwards Lifesciences headquartered?▼
Edwards Lifesciences is headquartered in IRVINE, United States.